Shepherd Kaplan Krochuk’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,000	Closed	-$28.7K	–	58
2024 Q1	$28.7K	Hold	12,000	–	–	0.02%	54
2023 Q4	$19.9K	Hold	12,000	–	–	0.02%	54
2023 Q3	$23K	Hold	12,000	–	–	0.02%	52
2023 Q2	$17.3K	Hold	12,000	–	–	0.01%	52
2023 Q1	$25.2K	Hold	12,000	–	–	0.02%	55
2022 Q4	$13.6K	Hold	12,000	–	–	0.01%	71
2022 Q3	$20K	Hold	12,000	–	–	0.01%	144
2022 Q2	$16K	Hold	12,000	–	–	0.01%	191
2022 Q1	$19K	Hold	12,000	–	–	0.01%	193
2021 Q4	$25K	Hold	12,000	–	–	0.01%	191
2021 Q3	$47K	Hold	12,000	–	–	0.02%	190
2021 Q2	$38K	Hold	12,000	–	–	0.01%	191
2021 Q1	$26K	Sell	12,000 -575	-5%	-$1.29K	0.01%	184
2020 Q4	$28K	Buy	12,575 +575	+5%	+$1.51K	0.01%	184
2020 Q3	$32K	Hold	12,000	–	–	0.01%	174
2020 Q2	$37K	Buy	+12,000	New	+$30.2K	0.02%	176